Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Ravaioli

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2018
Cell-Free DNA Integrity: ApplicationsSara Ravaioli
Breast Cancer Research and Treatment|February 27, 2018
What to look for in cell-free DNA from breast cancer patientsGiuseppe Bronte, Sara Ravaioli, Sara Bravaccini
Journal of Visualized Experiments : Jove|January 25, 2017
Cell-Free DNA Integrity Analysis in Urine SamplesValentina Casadio, Samanta Salvi, Filippo Martignano, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2020
Are we ready to use TMB in breast cancer clinical practice?Sara Ravaioli, Francesco Limarzi, Maria Maddalena Tumedei, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 3, 2017
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment?Sara Ravaioli, Maurizio Puccetti, Maria Maddalena Tumedei, et al.
Oncotarget|November 12, 2016
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histologySara Ravaioli, Sara Bravaccini, Maria Maddalena Tumedei, et al.
Journal of Lower Genital Tract Disease|September 10, 2016
Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ HybridizationSara Ravaioli, Maria M Tumedei, Andrea Amadori, et al.
Frontiers in Cell and Developmental Biology|January 23, 2023
Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiotaFrancesca Pirini, Michela Cortesi, Maria Maddalena Tumedei, et al.
Diagnostic Pathology|September 12, 2020
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be goldRoberta Maltoni, Michela Palleschi, Sara Ravaioli, et al.
Molecular Biology Reports|December 7, 2024
Human papillomavirus E6 alters Toll-like receptor 9 transcripts and chemotherapy responses in breast cancer cells in vitroEssi Parviainen, Sini Nurmenniemi, Sara Ravaioli, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2018
Cell-Free DNA Integrity: ApplicationsSara Ravaioli
Breast Cancer Research and Treatment|February 27, 2018
What to look for in cell-free DNA from breast cancer patientsGiuseppe Bronte, Sara Ravaioli, Sara Bravaccini
Journal of Visualized Experiments : Jove|January 25, 2017
Cell-Free DNA Integrity Analysis in Urine SamplesValentina Casadio, Samanta Salvi, Filippo Martignano, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2020
Are we ready to use TMB in breast cancer clinical practice?Sara Ravaioli, Francesco Limarzi, Maria Maddalena Tumedei, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 3, 2017
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment?Sara Ravaioli, Maurizio Puccetti, Maria Maddalena Tumedei, et al.
Oncotarget|November 12, 2016
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histologySara Ravaioli, Sara Bravaccini, Maria Maddalena Tumedei, et al.
Journal of Lower Genital Tract Disease|September 10, 2016
Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ HybridizationSara Ravaioli, Maria M Tumedei, Andrea Amadori, et al.
Frontiers in Cell and Developmental Biology|January 23, 2023
Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiotaFrancesca Pirini, Michela Cortesi, Maria Maddalena Tumedei, et al.
Diagnostic Pathology|September 12, 2020
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be goldRoberta Maltoni, Michela Palleschi, Sara Ravaioli, et al.
Molecular Biology Reports|December 7, 2024
Human papillomavirus E6 alters Toll-like receptor 9 transcripts and chemotherapy responses in breast cancer cells in vitroEssi Parviainen, Sini Nurmenniemi, Sara Ravaioli, et al.
Pageof 6